Neuroplasticity & Cognitive Reserve: Dementia Prevention
Quick Answer
Cognitive reserve, built through complex and novel mental activity, may delay the clinical onset of dementia by several years according to research by Yaakov Stern and the 2020 Lancet Commission on dementia prevention (1,2,7). Brain training stimulates brain-derived neurotrophic factor (BDNF) release, a protein essential for neuroplasticity, synaptic growth, and neuronal survival in the hippocampus (3). Functional medicine approaches pair cognitive training with strategies to reduce neuroinflammation and metabolic stress, helping ensure the brain can form and sustain new neural connections (4).
At a Glance
- Cognitive reserve may act as a protective buffer, allowing the brain to maintain function even as Alzheimer’s-related amyloid-beta pathology accumulates (1,7).
- Brain-derived neurotrophic factor (BDNF), upregulated by both cognitive challenge and aerobic exercise, supports hippocampal neurogenesis and synaptic plasticity (3,10).
- Elevated homocysteine is associated with accelerated brain atrophy; B-vitamin supplementation may slow this process by up to 53% in individuals with mild cognitive impairment (2,10).
- Insulin resistance in the brain, sometimes termed “Type 3 diabetes,” may impair synaptic plasticity and increase Alzheimer’s disease risk (4,8).
- The gut-brain axis can transmit inflammatory signals that inhibit neurogenesis, making gastrointestinal health a relevant factor in cognitive resilience.
- Approximately 150 minutes per week of moderate-intensity aerobic exercise is associated with increased hippocampal volume and improved memory, as demonstrated by Kirk Erickson’s landmark 2011 trial (3).
In the clinical landscape of cognitive aging, research increasingly supports the view that decline is not inevitable. The human brain is not a static organ — it remains highly adaptive across the lifespan, a principle established by Bogdan Draganski’s 2004 neuroimaging research published in Nature (6).
For patients in Adelaide concerned about memory loss, Rohan Smith at Elemental Health and Nutrition focuses on cognitive reserve: the brain’s ability to recruit alternate neural pathways to maintain function when others are compromised. Building cognitive reserve requires a dual strategy: targeted mental stimulation (brain training) combined with an optimised biological environment that supports neuroplastic change.
Neuroplasticity and the “Buffer” Effect
Neuroplasticity — the brain’s capacity to reorganise itself by forming new neural pathways — is the foundation of dementia risk reduction, as described by Valenzuela and Sachdev in their systematic review (5,6). When the brain is challenged with novel, complex tasks, synaptic density increases. This creates a functional “buffer.” Even if certain pathways are disrupted by ageing or amyloid-beta accumulation, the brain can draw on alternative networks to preserve cognitive function, a concept Yaakov Stern termed cognitive reserve in his 2012 Lancet Neurology paper (1,7).
For neuroplasticity to occur effectively, the brain must not be overwhelmed by oxidative stress or chronic systemic inflammation, both of which impair synaptic signalling and neuronal repair, as detailed by Heneka et al. in their 2015 Lancet Neurology review of neuroinflammation in Alzheimer’s disease (8,12).
Mechanisms of Brain Resilience
Three primary biological mechanisms underpin the brain’s capacity to build cognitive reserve and resist neurodegenerative decline (5,9,11).
| Mechanism | How It Works | Key Evidence |
|---|---|---|
| Synaptogenesis | Learning new skills — such as a language or musical instrument — drives the formation of new synapses, strengthening communication between brain regions (5,9). | Denise Park and Gérard Bischof demonstrated training-induced neuroplastic changes in ageing adults (9). |
| BDNF Production | Cognitive challenge, similar to physical exercise, upregulates BDNF expression in the hippocampus, a region particularly vulnerable in Alzheimer’s disease (3,10). | Kirk Erickson’s 2011 randomised controlled trial showed exercise-driven hippocampal volume increases of approximately 2% (3). |
| Cerebral Blood Flow | Sustained mental effort increases regional metabolic demand, supporting micro-circulation and oxygen delivery to active neural tissue (11,12). | Mark Mattson’s research linked neurotrophic signalling to improved cerebrovascular function (11). |
The Functional Medicine Edge: Creating the Environment for Growth
Brain training is most effective when the underlying biochemical environment supports adaptation — a chronically inflamed or metabolically stressed brain struggles to build new connections (4,8).
Key areas commonly assessed in a functional medicine evaluation include:
| Assessment Area | Clinical Relevance | Functional Approach |
|---|---|---|
| Methylation and Homocysteine | Elevated homocysteine is a recognised risk factor for brain atrophy and cognitive decline. The VITACOG trial by A. David Smith demonstrated that B-vitamin supplementation may slow brain atrophy in mild cognitive impairment (2,10). | Assessing B-vitamin status (B6, B12, folate) and MTHFR polymorphisms supports healthy methylation pathways involved in neuronal maintenance. Learn more about methylation and homocysteine. |
| Neurotransmitter Metabolites | Organic acid testing may reveal imbalances in dopamine or serotonin metabolism that influence focus, motivation, and learning capacity. | Targeted assessment of catecholamine and indolamine metabolites via urinary organic acid panels. |
| Gut-Brain Axis | Chronic gut inflammation can transmit inflammatory signals to the brain via the vagus nerve, inhibiting neurogenesis and promoting microglial activation. | Addressing gut-brain axis dysfunction is often a foundational step in cognitive support. |
When to Consider a Cognitive Assessment
Cognitive decline often begins decades before clinical diagnosis, with the 2020 Lancet Commission identifying 12 modifiable risk factors that account for approximately 40% of worldwide dementias (7). A review may be appropriate if you experience:
- Persistent brain fog or difficulty sustaining attention
- Cognitive symptoms alongside chronic fatigue and brain fog
- Reduced ability to learn new tasks that were previously intuitive
- A family history of neurodegenerative disease, including Alzheimer’s disease or Parkinson’s disease
Next Steps
- Engage in novel cognitive challenges: Prioritise progressively complex and unfamiliar mental tasks — once a task becomes familiar, cognitive gains plateau. Combine brain training with at least 150 minutes per week of moderate-intensity aerobic exercise to support BDNF production and hippocampal health, consistent with findings by Hillman, Erickson, and Kramer (14).
- Assess your biochemical environment: A functional assessment can help identify metabolic and inflammatory factors influencing your brain’s adaptive capacity, including methylation status, neurotransmitter balance, and gut-brain axis function.
Frequently Asked Questions
Key Insights
- Cognitive reserve acts as a protective buffer against neurodegenerative disease, potentially delaying symptom onset by several years (1,7)
- Neuroplasticity depends on both mental stimulation and a supportive biochemical environment free from chronic inflammation and oxidative stress (5,8)
- BDNF plays a central role in neuronal growth, repair, and resilience, particularly in the hippocampus (3,10)
- Elevated homocysteine is associated with accelerated brain atrophy, and B-vitamin intervention may slow this process (2,10)
- Supporting long-term cognitive and mental health requires addressing both lifestyle and metabolic factors
Citable Takeaways
- Yaakov Stern’s cognitive reserve model suggests that individuals with higher educational and occupational complexity may tolerate greater Alzheimer’s pathology before exhibiting clinical symptoms (Stern, 2012, Lancet Neurology).
- Kirk Erickson’s 2011 randomised controlled trial demonstrated that 12 months of moderate aerobic exercise increased hippocampal volume by approximately 2% and improved spatial memory in older adults (PNAS, 2011).
- The VITACOG trial by A. David Smith found that high-dose B-vitamin supplementation (folic acid, B6, B12) slowed the rate of brain atrophy by 53% over two years in individuals with mild cognitive impairment and elevated homocysteine (Smith et al., 2010, PLoS One).
- The 2020 Lancet Commission on dementia prevention identified 12 modifiable risk factors that together account for approximately 40% of worldwide dementias, supporting a multifactorial prevention strategy (Livingston et al., 2020).
- Dale Bredesen’s 2014 pilot programme combining metabolic optimisation, cognitive training, and lifestyle modification reported reversal of cognitive decline in 9 of 10 participants with early Alzheimer’s disease or mild cognitive impairment (Aging, 2014).
- Suzanne Craft’s research established that cerebral insulin resistance — sometimes called “Type 3 diabetes” — may impair synaptic plasticity and accelerate Alzheimer’s pathogenesis (Journal of Clinical Investigation, 2007).
Invest in Your Future Brain Health
Cognitive health is built over decades. A functional assessment can help identify metabolic and inflammatory factors influencing your brain’s adaptive capacity. At Elemental Health and Nutrition, Rohan Smith applies a systems-based framework to support long-term brain resilience and cognitive performance.
References
- Stern Y. Cognitive reserve in ageing and Alzheimer’s disease. Lancet Neurol. 2012 Nov;11(11):1006-12. https://doi.org/10.1016/S1474-4422(12)70191-6
- Smith AD et al. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS One. 2010 Sep 8;5(9):e12244. https://doi.org/10.1371/journal.pone.0012244
- Erickson KI et al. Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):3017-22. https://doi.org/10.1073/pnas.1015950108
- Bredesen DE. Reversal of cognitive decline: a novel therapeutic program. Aging (Albany NY). 2014 Sep;6(9):707-17. https://doi.org/10.18632/aging.100690
- Valenzuela MJ, Sachdev P. Can cognitive exercise prevent the onset of dementia? Systematic review. Psychol Med. 2009 Jan;39(1):1-11. https://doi.org/10.1017/S0033291708003626
- Draganski B et al. Neuroplasticity: changes in grey matter induced by training. Nature. 2004 Jan 22;427(6972):311-2. https://doi.org/10.1038/427311a
- Livingston G et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020 Aug 8;396(10248):413-446. https://doi.org/10.1016/S0140-6736(20)30367-6
- Craft S. Insulin resistance and Alzheimer’s disease pathogenesis: potential mechanisms and implications for treatment. J Clin Invest. 2007 May;117(5):1209-16. https://doi.org/10.1172/JCI31305
- Park DC, Bischof GN. The aging mind: neuroplasticity in response to cognitive training. Dialogues Clin Neurosci. 2013 Mar;15(1):109-19. https://pubmed.ncbi.nlm.nih.gov/23576892/
- Douaud G et al. Preventing Alzheimer’s disease-related gray matter atrophy by B-vitamin treatment. Proc Natl Acad Sci U S A. 2013 Jun 4;110(23):9523-8. https://doi.org/10.1073/pnas.1210127109
- Mattson MP. Glutamate and neurotrophic factors in neuronal plasticity and disease. Ann N Y Acad Sci. 2008 Dec;1147:1-13. https://doi.org/10.1196/annals.1427.001
- Heneka MT et al. Neuroinflammation in Alzheimer’s disease. Lancet Neurol. 2015 Apr;14(4):388-405. https://doi.org/10.1016/S1474-4422(15)70016-5
- Voss MW et al. Exercise-induced brain plasticity in humans: a review. Trends Cogn Sci. 2013 Aug;17(8):391-400. https://doi.org/10.1016/j.tics.2013.06.003
- Hillman CH et al. Be smart, exercise your heart: exercise effects on brain and cognition. Nat Rev Neurosci. 2008 Jan;9(1):58-65. https://doi.org/10.1038/nrn2298
- Passarino G et al. Lifestyle and genetics in cognitive decline and Alzheimer’s disease. Ageing Res Rev. 2016 Dec;32:1-10. https://doi.org/10.1016/j.arr.2016.08.003
